The approval broadens VEXIM’s potential market.
VEXIM is a medical device company focusing on the minimally invasive treatment of traumatic spinal pathologies.
More Articles on Devices:
New Developments in Knee Technology: ATTUNE® Rotating Platform & Anatomic Patella From DePuy Synthes Joint Reconstruction
Pain Management Devices Market in the U.S. to Reach Nearly $2.7B by 2022
Baxano Surgical Receives FDA 510(k) Clearance for Avance MIS Pedicle Screw System
